LKPC(SH:600789) Zhi Tong Cai Jing·2025-07-31 10:04Core Viewpoint - The company, LuKang Pharmaceutical (600789.SH), announced that its subsidiary, Shandong LuKang Pharmaceutical Group Saiter Co., Ltd., has received a drug registration certificate from the National Medical Products Administration for Vardenafil Hydrochloride Tablets, marking it as a generic drug approved under the new registration category 4, which has passed the consistency evaluation of quality and efficacy for generic drugs [1]. Group 1 - The drug Vardenafil Hydrochloride Tablets is a phosphodiesterase inhibitor that enhances the natural response to sexual stimulation by increasing blood flow to the penis, thus treating erectile dysfunction in men [1]. - The approval of this drug is significant as it indicates the company's capability to develop and market generic drugs that meet regulatory standards [1]. - The registration certificate number for the drug is 2025S02296, highlighting the formal recognition by the regulatory authority [1].